[ad_1]
(Reuters) – AstraZeneca Plc (L 🙂 said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.
AstraZeneca published an https: // document on Saturday outlining details of how the COVID-19 vaccine trial was being conducted, which was first reported by the New York Times.
Fusion Media or anyone involved with Fusion Media will not accept any responsibility for loss or damage as a result of reliance on information, including data, quotes, charts and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading financial markets, it is one of the riskiest investment forms possible.
[ad_2]